Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

NCT03611712 is registered in ClinicalTrials.gov with PhytoHealth Corporation as lead sponsor.

NCT NCT03611712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03611712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer
Lead sponsor
PhytoHealth Corporation
Phase
Phase 2
Overall status
Completed
Start date
February 19, 2019
Completion date
March 5, 2025
Enrollment
48 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related fatigue, survival, tumor, esophageal